Lamotrigine and blood dyscrasias
- various blood dyscrasias have been reported associated with the use of lamotrigine world-wide
- assessment of individual reports indicates that lamotrigine is likely to be the causative factor in the reported cases of blood dyscrasias associated with use of lamotrigine
- routine FBC monitoring is not, at present, recommended in patients treated with lamotrigine
Check the summary of product characteristics before prescribing this drug.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.